Granulocyte–macrophage colony‐stimulating factor (GM‐CSF) as a therapeutic target in psoriasis: randomized, controlled investigation using namilumab, a specific human anti‐GM‐CSF monoclonal antibody†

作者：K. Papp, Melinda J. Gooderham, R. Jenkins, R. Vender, J. Szepietowski, T. Wagner, Barbara Hunt, B. Souberbielle · 发表于：British Journal of Dermatology · 年份：2018 · DOI：10.1111/bjd.17195 · 被引用次数：41 · 研究领域：Medicine

The relevance of granulocyte–macrophage colony‐stimulating factor (GM‐CSF) in the management of psoriasis has not been studied previously. GM‐CSF is important in the initiation and maintenance of chronic inflammatory processes.